Risk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort study.

作者: Annalisa Rubino , Neil Roskell , Pat Tennis , Daniel Mines , Scott Weich

DOI: 10.1136/BMJ.39041.445104.BE

关键词: Absolute risk reductionFluoxetineRisk factorVenlafaxine HydrochlorideCitalopramPoison controlMedicinePsychiatryVenlafaxineDosulepin

摘要: Objective To compare the risk of suicide in adults using antidepressant venlafaxine compared with citalopram, fluoxetine, and dothiepin. Design Retrospective cohort study. Setting UK General Practice Research Database. Participants 219 088 patients, aged 18-89 years, who were prescribed venlafaxine, or dothiepin from 1995 to 2005. Main outcome measures Completed attempted suicide. Results Venlafaxine users had a higher burden factors for suicide, including previous attempts proxies severe depression that was difficult treat. In analysis completed suicides, unadjusted adjusted hazard ratios citalopram 2.44 (95% confidence interval 1.12 5.31) 1.70 (0.76 3.80), fluoxetine 2.85 (1.37 5.94) 1.63 (0.74 3.59), 2.54 (1.07 6.02) 1.31 (0.53 3.25). Compared other study drugs, also associated an increased but adjustment measured confounders substantially reduced ratios. Conclusions use consistently dothiepin. factors, however, excess risks. Since secondary data used this allowed only indirect partial measurements potential confounders, it is possible residual confounding explains much, if not all, observed risk.

参考文章(22)
Luis A. García Rodríguez, Susanne Pérez Gutthann, Use of the UK General Practice Research Database for pharmacoepidemiology British Journal of Clinical Pharmacology. ,vol. 45, pp. 419- 425 ,(1998) , 10.1046/J.1365-2125.1998.00701.X
Stephen M. Stahl, Meghan M. Grady, Chantal Moret, Mike Briley, SNRIs: The Pharmacology, Clinical Efficacy, and Tolerability in Comparison with Other Classes of Antidepressants CNS Spectrums. ,vol. 10, pp. 732- 747 ,(2005) , 10.1017/S1092852900019726
Daniel Mines, Deanna Hill, Holly Yu, Laura Novelli, Prevalence of risk factors for suicide in patients prescribed venlafaxine, fluoxetine, and citalopram. Pharmacoepidemiology and Drug Safety. ,vol. 14, pp. 367- 372 ,(2005) , 10.1002/PDS.1095
Hershel Jick, James A Kaye, Susan S Jick, Antidepressants and the risk of suicidal behaviors. JAMA. ,vol. 292, pp. 338- 343 ,(2004) , 10.1001/JAMA.292.3.338
Thomas R. Simon, Mark Anderson, Martie P. Thompson, Alex Crosby, Jeffrey J. Sacks, Assault victimization and suicidal ideation or behavior within a national sample of U.S. adults. Suicide and Life Threatening Behavior. ,vol. 32, pp. 42- 50 ,(2002) , 10.1521/SULI.32.1.42.22181
T Walley, A Mantgani, The UK General Practice Research Database. The Lancet. ,vol. 350, pp. 1097- 1099 ,(1997) , 10.1016/S0140-6736(97)04248-7
Rebecca C. Didham, Doug W. McConnell, Hayden J. Blair, David M. Reith, Suicide and self-harm following prescription of SSRIs and other antidepressants: confounding by indication British Journal of Clinical Pharmacology. ,vol. 60, pp. 519- 525 ,(2005) , 10.1111/J.1365-2125.2005.02480.X
Angela Plunkett, Brian O'Toole, Heather Swanston, R. Kim Oates, Sandra Shrimpton, Patrick Parkinson, Suicide Risk Following Child Sexual Abuse Ambulatory Pediatrics. ,vol. 1, pp. 262- 266 ,(2001) , 10.1367/1539-4409(2001)001<0262:SRFCSA>2.0.CO;2